FOXA2 and colorectal carcinoma: Targeting Nrf2 for its suppression by si‐Nrf2 or its inhibitor ML385 in FOXA2‐overexpressed CRC cells restored ROS levels, MDA contents, iron accumulation, and lipid peroxidation production.